No Data
No Data
Annovis Announces New Publication in a Peer-Reviewed Journal
Tue, 21 May 2024MALVERN, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neur
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Biocryst Pharmaceuticals, T2 Biosystems, Annovis Bio Among Healthcare Movers
Buy Rating Maintained for Annovis Bio Ahead of Key Parkinson's Drug Trial Results
10 Health Care Stocks With Whale Alerts In Today's Session
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Stocks With More Than 10% Short Interest - Finviz Screener